Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Auxly Cannabis Group Inc.

Start price
Target price
Perf. (%)
€0.29
02.06.20
€0.50
04.11.21
-47.10%
12.08.21

tbackenh 
02.06.20 50%
buy
Pensana Rare Earths Plc

Start price
Target price
Perf. (%)
€2.01
27.03.21
€2.00
27.03.22
-50.75%
12.08.21

Future proof or reliable business model
Risky balance sheet
tbackenh 
27.03.21 60%
buy
C3 Ai Inc.

Start price
Target price
Perf. (%)
€114.40
01.02.21
€115.00
01.02.22
-61.93%
12.08.21

Could be worthwhile Investment >10% per year
Innovative
Future proof or reliable business model
Some uniques
tbackenh 
01.02.21 60%
sell
Erytech Pharma S.a.

Start price
Target price
Perf. (%)
€4.80
30.07.21
-
30.07.22
6.25%
08.08.21

Risky Investment
Vassago1 
30.07.21 50%
buy
Odonate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.22
25.07.21
-
25.07.22
-9.32%
07.08.21

Could be worthwhile Investment >10% per year
Innovative
Good culture
Few uniques
me8 
25.07.21 0%
sell
Moxian Inc.

Start price
Target price
Perf. (%)
€17.50
25.07.21
€7.00
25.07.22
-57.14%
07.08.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
mixitrader 
25.07.21 50%
buy
Hexagon Purus As

Start price
Target price
Perf. (%)
€3.87
10.07.21
€4.00
10.07.22
-18.60%
30.07.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Lower EBIT Margin than peer group
geldnutzer 
10.07.21 60%
buy
Zacatecas Silver Corp.

Start price
Target price
Perf. (%)
€1.08
22.03.21
-
22.03.22
-44.44%
28.07.21

Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Undervalued
positive Cash Flow expected
FXX 
22.03.21 0%
buy
Clover Health Inv. Corp.

Start price
Target price
Perf. (%)
€8.10
09.07.21
-
09.07.22
-15.93%
24.07.21

Risky Investment
Global_Player 
09.07.21 50%
buy
Odonate Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.98
12.07.21
€5.00
12.07.22
8.05%
24.07.21

Could be worthwhile Investment >10% per year
Innovative
Good culture
Few uniques
me8 
12.07.21 0%
sell
Everarc Holdings Ltd.

Start price
Target price
Perf. (%)
€6.30
14.07.21
-
14.07.22
39.68%
24.07.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
mixitrader 
14.07.21 50%
sell
Desenio Holding Ab

Start price
Target price
Perf. (%)
€4.49
10.07.21
-
10.07.22
3.08%
24.07.21

EBIT decline/stagnation expected
Bad rating
negative Cash Flow expected
Bad culture
mixitrader 
10.07.21 50%
sell
Phunware Inc.

Start price
Target price
Perf. (%)
€0.62
22.10.20
-
04.11.21
53.06%
15.07.21

Risky Investment
Biotechhunter 
22.10.20 50%
sell
Nikola Corp.

Start price
Target price
Perf. (%)
€14.00
24.09.20
-
04.11.21
-14.81%
15.07.21

Risky Investment
overvalued
Biotechhunter 
24.09.20 50%
buy
Inspire Medical Systems Inc.

Start price
Target price
Perf. (%)
€99.00
04.09.20
-
04.11.21
50.81%
15.07.21

Biotechhunter 
04.09.20 50%
buy
Baidu Inc.

Start price
Target price
Perf. (%)
€21.70
28.06.21
-
28.06.22
-9.31%
14.07.21

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Market Leader or Top 3
Nicole 
28.06.21 50%
sell
Ether Capital Corp.

Start price
Target price
Perf. (%)
€2.06
11.03.21
-
11.03.22
0.00%
09.07.21

Revenue growth > 30% per year expected
EBIT decline > 20% expected
Probably not worthwhile Investment
robertinio 
11.03.21 100%
sell
Rubius Therapeutics Inc.

Start price
Target price
Perf. (%)
€7.30
14.12.20
-
14.12.21
169.86%
07.07.21

Probably not worthwhile Investment
marge 
14.12.20 50%
buy
DWS Group

Start price
Target price
Perf. (%)
€36.60
29.03.21
€43.00
29.06.21
5.25%
29.06.21

Fair valuation
Good rating
Small Risks for its business
Higher EBIT margin than peer group
Snowman 
29.03.21 50%
sell
Churchill Capital Corp. Iv

Start price
Target price
Perf. (%)
€21.30
10.06.21
€8.00
10.06.22
0.94%
28.06.21

Subdi 
10.06.21 50%
sell
Reconnaissance Energy Afri.ltd

Start price
Target price
Perf. (%)
€9.33
24.06.21
-
24.06.22
-22.83%
27.06.21

Risky Investment
daimler1 
24.06.21 50%
sell
Maxeon Solar Technologies Ltd.

Start price
Target price
Perf. (%)
€14.30
18.10.20
€7.00
04.11.21
21.33%
26.06.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
mixitrader 
18.10.20 50%
sell
Rubius Therapeutics Inc.

Start price
Target price
Perf. (%)
€7.90
14.12.20
€2.00
14.12.21
158.23%
26.06.21

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
nvestor 
14.12.20 50%
buy
Mediaco Holding Inc.

Start price
Target price
Perf. (%)
€3.96
14.06.21
€6.00
14.06.22
-21.21%
26.06.21

Could be worthwhile Investment >10% per year
Capable Management
Few uniques
me8 
14.06.21 0%
buy
Neoen S.a.

Start price
Target price
Perf. (%)
€34.94
14.06.21
€38.00
14.06.22
3.21%
24.06.21

Could be worthwhile Investment >10% per year
melinda 
14.06.21 50%